SCHEMBL5069843

SCHEMBL5069843

O=C(NCC1(C(F)C(=O)N2CCCC2C(F)(F)F)CCNCC1)c1cc(F)cc(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 7/20 0.40
CACNA1I Q9P0X4 3/20 0.39
CACNA1G O43497 1/20 0.39
KCNH2 Q12809 7/20 0.37
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
METAP2 P50579 2/20 0.34
CETP P11597 2/20 0.34
SCN5A Q14524 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5069860 0.95 KCNH2 (0.41) CACNA1HCACNA1ICACNA1GKCNH2SCN5A
SCHEMBL5071693 0.89 NPC1 (0.39) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL5069851 0.84 NPC1 (0.44) CACNA1GKCNH2
SCHEMBL2885759 0.76 KCNH2 (0.51) CACNA1HCACNA1ICACNA1GKCNH2TAS1R3
SCHEMBL4275164 0.75 CACNA1I (0.54) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL4282606 0.75 CACNA1I (0.54) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL4275172 0.75 CACNA1I (0.54) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL4285587 0.71 CACNA1I (0.64) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL4276607 0.71 CACNA1I (0.64) CACNA1HCACNA1ICACNA1GKCNH2
SCHEMBL4276610 0.71 CACNA1I (0.64) CACNA1HCACNA1ICACNA1GKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901746-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS Merck & Co., Inc. (US) 2008-03-26 EP claimed
WO-2007002884-A2 4-FLUORO-PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS MERCK & CO., INC. (US) 2007-01-04 WO claimed